Newark Beth Israel Medical Center
11
0
0
5
Key Highlights
Risk & Performance
Pipeline Risk Assessment
Pipeline Risk Assessment
Based on historical performance
Moderate Risk
Score: 40/100
9.1%
1 terminated/withdrawn out of 11 trials
83.3%
-3.2% vs industry average
45%
5 trials in Phase 3/4
40%
2 of 5 completed trials have results
Key Signals
Enrollment Performance
Analytics
Activity Timeline
Global Presence
Clinical Trials (11)
Comparative Effectiveness of Emergency Ultrasound Guided Management of Pediatric Soft Tissue Infections
Role: collaborator
Accuracy of Pediatric Emergency Medicine Providers in Diagnosing Hip Effusions Using Point of Care Ultrasound
Role: collaborator
Health-Related Quality of Life Outcomes and Bleeding Rates Among Patients With Severe Hemophilia A on Emicizumab
Role: lead
Lidocaine Intravenous in the Emergency Department For Sickle Cell Crisis
Role: collaborator
SPG Block for Acute Pediatric Migraine
Role: lead
Does IV Acetaminophen Reduce Opioid Requirement in Pediatric Patients With Acute Sickle Cell Crises?
Role: lead
Randomized Study of Organ Care System Cardiac for Preservation of Donated Hearts for Eventual Transplantation
Role: collaborator
Family Nurture Intervention in the CHoNJ NICU
Role: collaborator
Once-a-day Tacrolimus Conversion Study: The OneTAC Trial
Role: lead
Safety Outcomes of Lower Immunosuppression Versus Traditional Immunosuppression in Heart Transplant Recipients
Role: lead
Safety and Efficacy of the Novel Selective Nicotinic Receptor Partial Agonist, CHANTIX (Varenicline) in Patients With Acute Coronary Syndrome
Role: lead
All 11 trials loaded